BioLargo, Inc. (BLGO)
OTCMKTS
· Delayed Price · Currency is USD
0.2496
+0.0111 (4.65%)
May 12, 2025, 3:58 PM EDT
BioLargo Company Description
BioLargo, Inc. invents, develops, and commercializes various platform technologies.
The company’s technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation.
It provides full-service environmental engineering services. BioLargo, Inc. was founded in 1991 and is based in Westminster, California.
BioLargo, Inc.

Country | United States |
Founded | 1991 |
Industry | Chemicals |
Sector | Materials |
Employees | 44 |
CEO | Dennis Calvert |
Contact Details
Address: 14921 Chestnut Street Westminster, Delaware 92683 United States | |
Phone | 888 400 2863 |
Website | biolargo.com |
Stock Details
Ticker Symbol | BLGO |
Exchange | OTCMKTS |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | US09065A1007 |
SIC Code | 2860 |
Key Executives
Name | Position |
---|---|
Dennis P. Calvert | Chairman, President and Chief Executive Officer |
Charles K. Dargan II, C.F.A. | Chief Financial Officer |
Joseph L. Provenzano | Executive Vice President of Operations, Corporate Secretary and Director |
Kenneth Reay Code | Chief Science Officer and Director |
Alex Evans | Director of Corporate Communications |
Steven V. Harrison II | President of Clyra Medical Technologies Inc |
Randall Moore | President of BioLargo Engineering, Science and Technologies, LLC |
Dr. Richard Smith Ph.D. | President of BioLargo Canada, Inc. |
Tonya Chandler | President of BioLargo Equipment Solutions and Technologies, Inc. |